Ye Ye, MD
Payments from drug & device makers
Across 40 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$252
- Heron Therapeutics, Inc.$56
- Johnson & Johnson$54
- TELA Bio, Inc.$48
- Organogenesis Inc.$43
- Ambu Inc.$28
- plus $200 from 12 others
What the payments were for
- Food & beverage$680100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $252 |
| Heron Therapeutics, Inc. | 3 | $56 |
| Johnson & Johnson | 1 | $54 |
| TELA Bio, Inc. | 5 | $48 |
| Organogenesis Inc. | 2 | $43 |
| Ambu Inc. | 1 | $28 |
| Portola Pharmaceuticals, LLC | 1 | $28 |
| Smith+Nephew | 2 | $28 |
| Exact Sciences | 1 | $18 |
| Kerecis Limited | 1 | $17 |
| Medtronic | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| QOL Medical, LLC | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
| Biofire Diagnostics, LLC | 1 | $11 |
| Davol Inc. | 1 | $11 |
How this compares
$680 in reported general payments places this provider in the 45th percentile of 197 surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 55 | $566 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $224 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $93 |
Paid to pharmacies, not to this prescriber.
Other surgery in York
- Shaheed MeraniOmaha$563K
- Dmitry OleynikovOmaha$192K
- Benjamin HungLincoln$75K
- Gary AnthoneOmaha$74K
- David MercerOmaha$67K
- Jason WalshKearney$58K
- Vishal KothariOmaha$42K
- Moriah WrightOmaha$37K
- Andy YangOmaha$36K
- Matthew WheelerBellevue$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.